Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemia.

Jiménez P, Alvarez JC, Garrido P, Lorente JA, Palacios J, Ruiz-Cabello F.

Int J Biomed Sci. 2012 Dec;8(4):244-8.

2.

Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.

Gopcsa L, Barta A, Banyai A, Konya M, Pajor L, Földi J, Paloczi K.

Bone Marrow Transplant. 2002 Mar;29(5):449-52.

3.
4.

Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.

Cooley LD, Sears DA, Udden MM, Harrison WR, Baker KR.

Am J Hematol. 2000 Jan;63(1):46-53. Review.

PMID:
10602169
5.

Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor.

Bobadilla-Morales L, Pimentel-Gutiérrez HJ, Gallegos-Castorena S, Paniagua-Padilla JA, Ortega-de-la-Torre C, Sánchez-Zubieta F, Silva-Cruz R, Corona-Rivera JR, Zepeda-Moreno A, González-Ramella O, Corona-Rivera A.

Mol Cytogenet. 2015 Jan 31;8:5. doi: 10.1186/s13039-014-0105-4.

6.

Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.

Glasser L, Meloni-Ehrig A, Greaves W, Demel KC, Butera J.

Transfusion. 2009 Mar;49(3):555-62. doi: 10.1111/j.1537-2995.2008.02008.x.

PMID:
19040490
7.

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE; Center for International Blood and Marrow Transplant Research.; Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation).; National Cord Blood Program of the New York Blood Center..

Lancet Oncol. 2010 Jul;11(7):653-60. doi: 10.1016/S1470-2045(10)70127-3.

8.

[Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].

He YX, Xue YQ, Wang HY, Shao XJ, Pan JL, Xu J, Yang NC, Ji ZH, Huang YP, Hu SY.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Dec;29(6):677-82. doi: 10.3760/cma.j.issn.1003-9406.2012.06.011. Chinese.

PMID:
23225048
9.

Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization.

Lowsky R, Fyles G, Minden M, Lipton J, Meharchand J, Tejpar I, Zipursky A, Messner H.

Br J Haematol. 1996 Apr;93(1):163-5.

PMID:
8611454
11.

Comparative Study of FISH, PCR and Cytogenetics on 25 Patients Submitted to Bone Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); Which Tests can we Use in Routine Analysis Post BMT?

Palka G, Lawler M, Morizio E, Gardiner N, Stuppia L, De Arce MA, Di Bartolomeo PD, Capodiferro F, Sabatino G, Gatta V, Calabrese G, Cann SR.

Hematology. 1998;3(3):193-203. doi: 10.1080/10245332.1998.11746391.

PMID:
27416528
12.

PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor.

Shinzato A, Tabuchi K, Atsuta Y, Inoue M, Inagaki J, Yabe H, Koh K, Kato K, Ohta H, Kigasawa H, Kitoh T, Ogawa A, Takahashi Y, Sasahara Y, Kato S, Adachi S.

Pediatr Blood Cancer. 2013 Sep;60(9):1513-9. doi: 10.1002/pbc.24524.

PMID:
23512888
13.

Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.

Ferrari A, Bussaglia E, Úbeda J, Facchini L, Aventin A, Sierra J, Nomdedéu JF.

Hematol Oncol. 2012 Sep;30(3):109-14. doi: 10.1002/hon.1011.

PMID:
21812014
14.
15.

Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life.

Beelen DW, Quabeck K, Mahmoud HK, Schaefer UW, Becher R, Schmidt CG, Bamberg M, Quast U, Grosse-Wilde H, Haralambie E, et al.

Eur J Cancer Clin Oncol. 1987 Nov;23(11):1665-71.

PMID:
3322846
16.
17.

Expression of cell-surface antigens in acute promyelocytic leukaemia.

Paietta E.

Best Pract Res Clin Haematol. 2003 Sep;16(3):369-85. Review.

PMID:
12935957
18.

Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.

Daly AS, Kamel-Reid S, Lipton JH, Messner HA, Kiss TL, Chun K, Busque L, Chang H.

Leuk Res. 2004 Oct;28(10):1107-11.

PMID:
15289025
19.

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE.

Lancet. 2007 Jun 9;369(9577):1947-54.

PMID:
17560447
20.

Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.

Matsunaga T, Murase K, Yoshida M, Fujimi A, Iyama S, Kuribayashi K, Sato T, Kogawa K, Hirayama Y, Sakamaki S, Kohda K, Niitsu Y.

Am J Hematol. 2005 Aug;79(4):294-8.

Supplemental Content

Support Center